• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型非甾体抗炎药:2-(5-乙基吡啶-2-基)苯并咪唑(KB-1043)的药理学研究

Pharmacological studies of a new non-steroidal antiinflammatory drug: 2-(5-ethylpyridin-2-yl)benzimidazole (KB-1043).

作者信息

Ito K, Kagaya H, Fukuda T, Yoshino K, Nose T

出版信息

Arzneimittelforschung. 1982;32(1):49-55.

PMID:6977364
Abstract

2-(5-Ethylpyridin-2-yl)benzimidazole (KB-1043) is a new benzimidazole derivative with marked antiinflammatory, analgesic and antipyretic properties. KB-1043 possesses potent inhibitory activities on the acute inflammatory edema induced by chemical and physical irritants in the hind paw of rats, but almost ineffective (similar to tiaramide) against adjuvant-induced polyarthritis in the rat. The antagonistic effects of KB-1043 on increased vascular permeability are more potent than those of phenylbutazone, and the analgesic effects of KB-1043 on the pain induced by chemical and mechanical stimulations were nearly equal to, or slightly less potent than, those of tiaramide and phenylbutazone. The fevers induced by brewer's yeast and polysaccharide from Pseudomonas fluorescens (T.T.G.) were lowered by KB-1043. THe ulcerogenic activity of KB-1043 was weaker than those of tiaramide and phenylbutazone. The therapeutic index of KB-1043 therefore is superior to those of tiaramide and phenylbutazone.

摘要

2-(5-乙基吡啶-2-基)苯并咪唑(KB-1043)是一种新型苯并咪唑衍生物,具有显著的抗炎、镇痛和解热特性。KB-1043对大鼠后爪由化学和物理刺激诱导的急性炎性水肿具有强效抑制活性,但对大鼠佐剂诱导的多关节炎几乎无效(类似于替拉米特)。KB-1043对血管通透性增加的拮抗作用比保泰松更强,且KB-1043对化学和机械刺激诱导的疼痛的镇痛作用几乎与替拉米特和保泰松相当,或略弱于它们。KB-1043可降低啤酒酵母和荧光假单胞菌多糖(T.T.G.)诱导的发热。KB-1043的致溃疡活性比替拉米特和保泰松弱。因此,KB-1043的治疗指数优于替拉米特和保泰松。

相似文献

1
Pharmacological studies of a new non-steroidal antiinflammatory drug: 2-(5-ethylpyridin-2-yl)benzimidazole (KB-1043).一种新型非甾体抗炎药:2-(5-乙基吡啶-2-基)苯并咪唑(KB-1043)的药理学研究
Arzneimittelforschung. 1982;32(1):49-55.
2
The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.2-(8-甲基-10,11-二氢-11-氧代二苯并[b,f]氧杂卓-2-基)丙酸(AD-1590)的药理学特征,一种具有强效解热活性的新型非甾体抗炎药。
Arzneimittelforschung. 1983;33(11):1555-69.
3
Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac.新型强效非甾体抗炎药醋氯芬酸的药理学
Arzneimittelforschung. 1991 Dec;41(12):1265-76.
4
The studies of the mechanism of antiinflammatory action of 2-(5-ethylpyridin-2-yl)benzimidazole (KB-1043).
Arzneimittelforschung. 1982;32(2):117-22.
5
Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-o ne. 1st communication: antiinflammatory, analgesic and other related properties.新型抗炎药3-甲酰氨基-7-甲基磺酰氨基-6-苯氧基-4H-1-苯并吡喃-4-酮的药理学研究。首次通讯:抗炎、镇痛及其他相关性质。
Arzneimittelforschung. 1992 Jul;42(7):935-44.
6
Pharmacological properties of droxicam, a new non-steroidal anti-inflammatory agent.新型非甾体抗炎药屈昔康的药理特性
Methods Find Exp Clin Pharmacol. 1986 Jul;8(7):407-22.
7
Pharmacological properties of the anti-inflammatory agent pyridyl-biphenylyl-acetamide (diphenpyramide).抗炎药吡啶基 - 联苯基 - 乙酰胺(二苯吡胺)的药理特性。
Arzneimittelforschung. 1977;27(11):2086-93.
8
Pharmacological and toxicological studies of a new non-steroidal anti-inflammatory drug: KC-8973.
Arzneimittelforschung. 1981;31(7):1105-10.
9
Anti-inflammatory, analgesic, and antipyretic effects and gastrointestinal toxicity of the new anti-inflammatory drug N-(3-[3-(piperidinylmethyl)phenoxy]propyl)-carbamoylmethylthio ]ethyl 1-(p-chlorobenzoyl) 5-methoxy-2-methyl-3-indolylacetate.新型抗炎药N-(3-[3-(哌啶基甲基)苯氧基]丙基)-氨甲酰甲基硫代]乙基1-(对氯苯甲酰基)-5-甲氧基-2-甲基-3-吲哚乙酸酯的抗炎、镇痛和解热作用及胃肠道毒性
Arzneimittelforschung. 1992 Jul;42(7):954-8.
10
Synthesis and antiinflammatory activity of some 2-(substituted-pyridinyl)benzimidazoles.
J Med Chem. 1980 Jul;23(7):734-8. doi: 10.1021/jm00181a007.

引用本文的文献

1
Structure-Activity Relationship Analysis of Benzimidazoles as Emerging Anti-Inflammatory Agents: An Overview.作为新型抗炎药物的苯并咪唑类化合物的构效关系分析:综述
Pharmaceuticals (Basel). 2021 Jul 11;14(7):663. doi: 10.3390/ph14070663.
2
Selective Synthesis of Benzimidazoles from -Phenylenediamine and Aldehydes Promoted by Supported Gold Nanoparticles.负载型金纳米粒子促进的邻苯二胺与醛选择性合成苯并咪唑
Nanomaterials (Basel). 2020 Dec 1;10(12):2405. doi: 10.3390/nano10122405.
3
A Facile Synthesis, In vitro Antiinflammatory and Antioxidant activity of Novel Benzimidazolylpyrano[2,3-d][1,3]thiazolocarbonitriles.
新型苯并咪唑基吡喃并[2,3 - d][1,3]噻唑碳腈的简便合成、体外抗炎和抗氧化活性
Indian J Pharm Sci. 2014 Nov-Dec;76(6):510-8.
4
In vitro metabolism of 2-(5-ethylpyridin-2-yl)benzimidazole.
Eur J Drug Metab Pharmacokinet. 1988 Jan-Mar;13(1):47-51. doi: 10.1007/BF03189928.
5
In vivo metabolism of the anti-inflammatory agent 2-(5-ethylpyridin-2-yl)benzimidazole.
Eur J Drug Metab Pharmacokinet. 1989 Oct-Dec;14(4):263-8. doi: 10.1007/BF03190109.